Cargando…

Synthesis and evaluation of highly releasable and structurally stable antibody-SN-38-conjugates

Camptothecins, traditional chemotherapy drugs, have been clinically used in antibody-drug conjugates (ADCs), which refreshes the recognition that ADCs preferably incorporate highly potent payloads. However, SN-38, active metabolite of irinotecan from camptothecins, tended to be incorporated into ADC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lianqi, Xie, Fei, Xiao, Dian, Xu, Xin, Su, Zheng, Wang, Yanming, Fan, Shiyong, Zhou, Xinbo, Li, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8676668/ https://www.ncbi.nlm.nih.gov/pubmed/34894942 http://dx.doi.org/10.1080/10717544.2021.2008053

Ejemplares similares

Antibody–drug conjugates: Recent advances in linker chemistry
por: Su, Zheng, et al.
Publicado: (2021)

Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety
por: Wang, Yanming, et al.
Publicado: (2020)

Development of applicable thiol-linked antibody–drug conjugates with improved stability and therapeutic index
por: Wang, Yanming, et al.
Publicado: (2022)

A bifunctional molecule-based strategy for the development of theranostic antibody-drug conjugate
por: Xiao, Dian, et al.
Publicado: (2021)

Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy
por: Wang, Yanming, et al.
Publicado: (2019)

From prodrug to pro-prodrug: hypoxia-sensitive antibody–drug conjugates
por: Wang, Yanming, et al.
Publicado: (2022)

Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2
por: Fan, Shiyong, et al.
Publicado: (2020)

Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload
por: Wang, Yanming, et al.
Publicado: (2017)

Synthesis and Antitumor Evaluation of Biotin-SN38-Valproic Acid Conjugates
por: Dai, Yi, et al.
Publicado: (2023)

Design, Synthesis, and In Vitro Evaluation of the Photoactivatable Prodrug of the PARP Inhibitor Talazoparib
por: Li, Jiaguo, et al.
Publicado: (2020)

Synthesis and Biological Evaluation of Novel 10-Substituted-7-ethyl-10-hydroxycamptothecin (SN-38) Prodrugs
por: Zhou, Mo, et al.
Publicado: (2014)

Synthesis, characterization, and evaluation of mPEG–SN38 and mPEG–PLA–SN38 micelles for cancer therapy
por: Xie, Jing, et al.
Publicado: (2016)

Carbon dots conjugated to SN38 for improved colorectal anticancer therapy
por: Mattinzoli, Deborah, et al.
Publicado: (2022)

Guanidine-modified albumin-MMAE conjugates with enhanced endocytosis ability
por: Yi, Ce, et al.
Publicado: (2023)

Does sacituzumab-govitecan act as a conventional antibody drug conjugate (ADC), a prodrug of SN-38 or both?
por: Santi, Daniel V., et al.
Publicado: (2021)

Linker Design Impacts Antibody-Drug Conjugate Pharmacokinetics and Efficacy via Modulating the Stability and Payload Release Efficiency
por: Su, Dian, et al.
Publicado: (2021)

Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy
por: Xing, Jing, et al.
Publicado: (2019)

Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable Thiol Conjugation
por: Christie, R. James, et al.
Publicado: (2017)

Investigation into the Efficacy of Val-SN-38, a Valine-Ester Prodrug of the Anti-Cancer Agent SN-38
por: Kwak, Eun-Young, et al.
Publicado: (2012)

Human Serum Albumin Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN38) for Cancer Treatment
por: Sepehri, Nima, et al.
Publicado: (2014)

Cholesterol-Inulin Conjugates for Efficient SN38 Nuclear Delivery: Nanomedicines for Precision Cancer Therapy
por: Mauro, Nicolò, et al.
Publicado: (2022)

Template directed synthesis of antibody Fc conjugates with concomitant ligand release
por: Postupalenko, Viktoriia, et al.
Publicado: (2022)

Design, Synthesis, and Renal Targeting of Methylprednisolone-Lysozyme
por: Pan, Xingquan, et al.
Publicado: (2020)

An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells
por: Yashiro, M, et al.
Publicado: (2011)

Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity
por: Liu, Yi, et al.
Publicado: (2015)

Development of Self-Associating SN-38-Conjugated Poly(ethylene oxide)-Poly(ester) Micelles for Colorectal Cancer Therapy
por: Sadat, Sams M. A., et al.
Publicado: (2020)

Inhibitory effects of NSAID-conjugated SN-38 on the viability of A549 Non-small cell lung cancer cells
por: Kwon, Hae–Won, et al.
Publicado: (2023)

Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells
por: TANAKA, TETSUJI, et al.
Publicado: (2012)

Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy
por: Zhong, Zhi-Xin, et al.
Publicado: (2023)

Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer
por: Perrone, Emanuele, et al.
Publicado: (2020)

Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates
por: Pillow, Thomas H., et al.
Publicado: (2017)

In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes
por: Chen, Min, et al.
Publicado: (2017)

Synthesis and Evaluation of Camptothecin Antibody–Drug Conjugates
por: Li, Wei, et al.
Publicado: (2019)

Single Protein Encapsulated SN38 for Tumor-Targeting Treatment
por: Yu, Changjun J., et al.
Publicado: (2023)

PEG–Ursolic Acid Conjugate: Synthesis and In Vitro Release Studies
por: Zacchigna, Marina, et al.
Publicado: (2014)

A method for controlling the synthesis of stable twisted two-dimensional conjugated molecules
por: Li, Yongjun, et al.
Publicado: (2016)

Synthesis, Physical Properties, and Reactivity of Stable, π-Conjugated, Carbon-Centered Radicals
por: Kubo, Takashi
Publicado: (2019)

Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects
por: Sapra, Puja, et al.
Publicado: (2011)

Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
por: Bi, Ye, et al.
Publicado: (2018)

SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study
por: Fang, Yi-Ping, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jv0h6a7tmqpfju1c3ussk0o338